MYLOTARG 5 mg

MYLOTARG (Gemtuzumab)

MYLOTARG

Gemtuzumab

single-unit of 5 mg 

Pfizer

Medical Use

Mylotarg is a prescription medication specifically designed to treat certain forms of acute myeloid leukemia (AML), a type of cancer that impacts myeloid cells in the bone marrow. These cells are precursors to red blood cells, white blood cells, and platelets.

This medication is particularly effective against CD33-positive AML, where the cancer cells exhibit high levels of the CD33 protein on their surface. The majority of AML cases fall into this category.

Mylotarg is prescribed for CD33-positive AML in the following scenarios:

  • -Newly diagnosed cases: Suitable for both adults and children aged 1 month and older.
  • -Relapsed or refractory cases: Used for adults and children aged 2 years and older.